Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Cambrex Unveils New Liquid-Phase Peptide Synthesis Technology

Friday, September 20, 2024

Cambrex has announced that its subsidiary Snapdragon Chemistry has successfully developed a new liquidphase peptide synthesis LPPS technology The new LPPS technology significantly reduces solvent consumption and the use of excess reagents offering a...

Axcelead Enters into Agreement with Acadia Pharmaceuticals for Drug Discovery

Friday, September 20, 2024

Axcelead Drug Discovery partners have entered into a Master Service agreement with Acadia Pharmaceuticals The new agreement enables Axcelead DDP to further assist Acadias drug discovery initiatives through its integrated drug discovery platform and e...

Merck's KEYTRUDA Plus Chemotherapy Approved by FDA for Advanced Malignant Pleural Mesothelioma

Thursday, September 19, 2024

Merck has received approval from the US Food and Drug Administration FDA for its antiPD therapy KEYTRUDA in combination with pemetrexed and platinumbased chemotherapy for the firstline treatment of adult patients with unresectable advanced or metasta...

Accord BioPharma Announces FDA Approval of 420mg Strength of HERCESSI™ for HER2-Positive Cancers

Thursday, September 19, 2024

Accord BioPharma has received approval from the US Food and Drug Administration FDA for a mg strength of HERCESSI trastuzumabstrf a biosimilar to Herceptin trastuzumab HERCESSI is designed for the adjuvant treatment of HERoverexpressing breast cancer

Senhwa Biosciences Submits IND for Pidnarulex in NCI-Sponsored Advanced Tumour Trial

Wednesday, September 18, 2024

Senhwa Biosciences has announced that an Investigational New Drug IND application for its experimental therapy Pidnarulex CX has been submitted to the US FDA Pidnarulex is a firstinclass small molecule that works by stabilising Gquadruplex G structur...

GSK Announces New Drug Application for Blenrep in Combination with Bortezomib

Wednesday, September 18, 2024

GSK has announced that Japans Ministry of Health Labour and Welfare MHLW has accepted a new drug application NDA for Blenrep belantamab mafodotin in combination with either bortezomib plus dexamethasone BorDex or pomalidomide plus dexamethasone PomDe...

BioMed X Launches New Immuno-Oncology Research Team with Ono Pharmaceutical

Wednesday, September 18, 2024

BioMed X has launched a new research team at its facility in Heidelberg The focus of the project is to explore the role of neutrophils in cancer with the aim of developing new immunotherapies

Debiopharm & WhiteLab Genomics Partner to Advance Oncology Drug Design

Tuesday, September 17, 2024

Debiopharm has formed a partnership with WhiteLab Genomics WLG to establish tomorrows standardofcare to cure cancer and infectious diseases The collaboration aims to achieve two key objectives identifying cancerspecific receptors overexpressed on can...

Korro Bio Enters into Collaboration with Novo Nordisk to Develop RNA-Based Therapies

Tuesday, September 17, 2024

Korro Bio has announced a collaboration with Novo Nordisk a global healthcare company to develop new genetic treatments The need for innovative approaches to treat cardiometabolic conditions such as obesity diabetes and cardiovascular diseases remain...

MaxCyte Enters into Partnership with Kamau Therapeutics to Advance Gene Therapy Development

Monday, September 16, 2024

MaxCyte has announced a strategic platform licence SPL agreement with Kamau Therapeutics MaxCytes ExPERT platform represents the next generation of electroporation technology offering high transfection efficiency scalability and advanced functionalit...